Volume 5 Supplement 1

New developments in Hematology and Oncology in 2011

Meeting abstracts

Edited by Qifa Liu, Yangqiu Li and Delong Liu

New developments in Hematology and Oncology in 2011. Go to conference site.

Guangzhou, China25-26 December 2011

Concatenated PDF 5S1

Targeted therapy in head/neck and gastric cancers

Authors: Chung-Tsen Hsueh

Citation: Journal of Hematology & Oncology 2012 5(Suppl 1):A1

Content type: Meeting abstract Published on: 25 April 2012
- View Full Text
- View PDF
Utilizing CD30 expression as a rational target for therapy of lymphoma

Authors: Won Seog Kim

Citation: Journal of Hematology & Oncology 2012 5(Suppl 1):A2

Content type: Meeting abstract Published on: 25 April 2012
- View Full Text
- View PDF
T-cell immunodeficiency and reconstruction based on TCR rearrangement analysis in hematological malignancy: update from 2011 ASH annual meeting

Authors: Yangqiu Li

Citation: Journal of Hematology & Oncology 2012 5(Suppl 1):A3

Content type: Meeting abstract Published on: 25 April 2012
- View Full Text
- View PDF
Recent advances in myelodysplasia: update from 2011 ASH annual meeting

Authors: Delong Liu

Citation: Journal of Hematology & Oncology 2012 5(Suppl 1):A4

Content type: Meeting abstract Published on: 25 April 2012
- View Full Text
- View PDF
Restoration of T cell tolerance in primary ITP

Authors: Xin-guang Liu, Jun Peng and Ming Hou

Citation: Journal of Hematology & Oncology 2012 5(Suppl 1):A5

Content type: Meeting abstract Published on: 25 April 2012
- View Full Text
- View PDF
Overcoming Gleevec-resistance by blocking oncogene addiction in malignant hematologic cells

Authors: Jingxuan Pan

Citation: Journal of Hematology & Oncology 2012 5(Suppl 1):A6

Content type: Meeting abstract Published on: 25 April 2012
- View Full Text
- View PDF
Targeting p53 by small molecule p53 activators in multiple myeloma

Authors: Manujendra N Saha, Yijun Yang and Hong Chang

Citation: Journal of Hematology & Oncology 2012 5(Suppl 1):A7

Content type: Meeting abstract Published on: 25 April 2012
- View Full Text
- View PDF
Epstein - Barr virus - associated Diseases in Allogeneic Hematopoietic Stem Cell Transplantation

Authors: Xiu-li Wu and Qi-fa Liu

Citation: Journal of Hematology & Oncology 2012 5(Suppl 1):A8

Content type: Meeting abstract Published on: 25 April 2012
- View Full Text
- View PDF

New developments in Hematology and Oncology in 2011

Meeting abstracts

Targeted therapy in head/neck and gastric cancers

Utilizing CD30 expression as a rational target for therapy of lymphoma

T-cell immunodeficiency and reconstruction based on TCR rearrangement analysis in hematological malignancy: update from 2011 ASH annual meeting

Recent advances in myelodysplasia: update from 2011 ASH annual meeting

Restoration of T cell tolerance in primary ITP

Overcoming Gleevec-resistance by blocking oncogene addiction in malignant hematologic cells

Targeting p53 by small molecule p53 activators in multiple myeloma

Epstein - Barr virus - associated Diseases in Allogeneic Hematopoietic Stem Cell Transplantation

Official journal of

Follow

Annual Journal Metrics

On the blog

PEAR-TREE: Understanding the usefulness of the PEAR-BIO platform in patients with kidney cancer

Winners of the 2022 Cardio-Oncology Journal Prize

Brain Tumor Awareness Month: Can proton beam therapy improve the long-term quality of life of patients with oligodendroglioma brain tumors?

Institutional membership

Funding your APC

Journal of Hematology & Oncology

Contact us

New developments in Hematology and Oncology in 2011

Meeting abstracts

Official journal of

Follow

Annual Journal Metrics

On the blog

Institutional membership

Funding your APC

​​​​​​​​​

Journal of Hematology & Oncology

Contact us